IS4726A - Treatment of brain damage due to trauma - Google Patents

Treatment of brain damage due to trauma

Info

Publication number
IS4726A
IS4726A IS4726A IS4726A IS4726A IS 4726 A IS4726 A IS 4726A IS 4726 A IS4726 A IS 4726A IS 4726 A IS4726 A IS 4726A IS 4726 A IS4726 A IS 4726A
Authority
IS
Iceland
Prior art keywords
trauma
treatment
damage due
brain damage
brain
Prior art date
Application number
IS4726A
Other languages
Icelandic (is)
Inventor
R. Pike Brian
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of IS4726A publication Critical patent/IS4726A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
IS4726A 1995-11-06 1998-04-27 Treatment of brain damage due to trauma IS4726A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK123295 1995-11-06
PCT/DK1996/000458 WO1997017074A1 (en) 1995-11-06 1996-11-05 Treatment of traumatic brain injury

Publications (1)

Publication Number Publication Date
IS4726A true IS4726A (en) 1998-04-27

Family

ID=8102484

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4726A IS4726A (en) 1995-11-06 1998-04-27 Treatment of brain damage due to trauma

Country Status (18)

Country Link
EP (1) EP0866706A1 (en)
JP (1) JPH11514654A (en)
KR (1) KR19990067353A (en)
AU (1) AU706594B2 (en)
BG (1) BG63150B1 (en)
BR (1) BR9611396A (en)
CA (1) CA2234824A1 (en)
CZ (1) CZ287441B6 (en)
EA (1) EA000531B1 (en)
HU (1) HUP9901051A2 (en)
IS (1) IS4726A (en)
NO (1) NO982036L (en)
NZ (1) NZ321546A (en)
PL (1) PL326490A1 (en)
SK (1) SK58198A3 (en)
TR (1) TR199800801T2 (en)
WO (1) WO1997017074A1 (en)
ZA (1) ZA969320B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR013096A1 (en) * 1997-07-01 2000-12-13 Lundbeck & Co As H SALE OF ADDITION OF MALEIC ACID OF 5- (2-ETIL-2-H-TETRAZOL-5-IL) -1-METHYL-1,2,3,6-TETRAHIDROPIRIDINA, PHARMACEUTICAL COMPOSITION THAT CONTAINS IT, ITS USE IN THERAPY AND METHOD OF PREPARATION OF THE SAME.
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
CA2620333A1 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
JP2009513672A (en) 2005-10-31 2009-04-02 ブレインセルス，インコーポレイティド GABA receptor-mediated regulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
JP2009536669A (en) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド Neurogenesis by angiotensin regulation
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
US5328925A (en) * 1989-02-22 1994-07-12 Novo Nordisk A/S Piperidine compounds and their use
IE922270A1 (en) * 1991-07-26 1993-01-27 Akzo Nv Pyrazole derivatives
US5330994A (en) * 1992-03-24 1994-07-19 Warner-Lambert Company Tetrahydropyridine isoxazoline derivatives

Also Published As

Publication number Publication date
KR19990067353A (en) 1999-08-16
CA2234824A1 (en) 1997-05-15
CZ287441B6 (en) 2000-11-15
EA000531B1 (en) 1999-10-28
EP0866706A1 (en) 1998-09-30
HUP9901051A2 (en) 2000-03-28
NO982036L (en) 1998-06-25
SK58198A3 (en) 1998-10-07
ZA969320B (en) 1997-05-30
BG102480A (en) 1999-01-29
PL326490A1 (en) 1998-09-28
NZ321546A (en) 2000-12-22
NO982036D0 (en) 1998-05-05
WO1997017074A1 (en) 1997-05-15
CZ138998A3 (en) 1998-10-14
BR9611396A (en) 1999-07-13
AU706594B2 (en) 1999-06-17
EA199800434A1 (en) 1998-10-29
BG63150B1 (en) 2001-05-31
AU7490096A (en) 1997-05-29
JPH11514654A (en) 1999-12-14
MX9803432A (en) 1998-09-30
TR199800801T2 (en) 1998-08-21

Similar Documents

Publication Publication Date Title
FI964874A (en) Treatment of vegetables
NO982172D0 (en) Use of epinastine for the treatment of pain
DE69618188D1 (en) COSMETIC SKIN TREATMENT PROCESS
NO952573D0 (en) Preparations for the treatment of diabetic complications
DE69635311D1 (en) ELECTROCHIRUGIC TISSUE REMOVAL
DE69615105T2 (en) Enzymatic treatment of cocoa
NO976063D0 (en) Procedure for the treatment of diabetes
DE69500089T3 (en) Treatment of poultry
DE69626539D1 (en) topical use of vitamin D for the treatment of eye diseases
NO963785D0 (en) Process for the treatment of 5HT2B receptor-related conditions
FI956339A (en) Treatment of absence of hypothalamic menstruation
DE69635708D1 (en) TETRANDRIN FOR THE TREATMENT OF EYE IGNITIONS
DE69807466T2 (en) TRIPTOLID DERIVATIVES USEFUL FOR THE TREATMENT OF AUTOIMMUNE DISEASES
IS4726A (en) Treatment of brain damage due to trauma
FI930182A0 (en) Method for the treatment of industrially germinable seed for human consumption
NO981866D0 (en) Therapeutic use of hemoglobin to promote wound healing
NO982582D0 (en) Procedure for treating pain
NO982562D0 (en) Composition for the treatment of pain
KR970038973U (en) Water treatment filter
NO962812D0 (en) Procedure for the treatment of pneumonia
DE29513387U1 (en) Treatment couch
DE9418331U1 (en) Treatment couch
KR960025637U (en) Easy to adjust connector
NO171565C (en) PROCEDURE FOR TREATMENT OF MANGANSLAM
NO931803D0 (en) TREATMENT OF TISSUE SULKATION